Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ME 3221

Known as: ME-3221, ME3221 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Oral administration of the angiotensin AT1 receptor antagonist 3-methyl-2,6-dimethyl-4-[[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl… Expand
Is this relevant?
1996
1996
1. A comparison was made on the protective effects of the following: ME3221, a competitive angiotensin AT1 receptor antagonist… Expand
Is this relevant?
1996
1996
The protective effects of ME3221, 3-methoxy-2,6-dimethyl-4-[[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-y l]methoxy] pyridine, on aged… Expand
Is this relevant?
1996
1995
1995
The pharmacological profile of a new surmountable angiotensin AT1 receptor antagonist, ME3221, 3-methoxy-2,6-dimethyl-4-[[2'-(1H… Expand
Is this relevant?
1995
1995
1. The protective effect of ME3221, a surmountable AT1 antagonist, on the hypertension and its concomitant complications in aged… Expand
Is this relevant?